Future Cardiol. 2012;8(5):707-728. These data come from reports of ototoxicity of 6.4% with furosemide compared with 1 and <1% for bumetanide and torsemide, respectively. [38] Acute kidney failure ...

Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in ...

A single dose of kanamycin (1,000 mg/kg) followed by furosemide (100 mg/kg; Sigma-Aldrich ... increased kanamycin-induced SG formation in HEI-OC1 cells To investigate the impact of METTL3 on kanamycin ...

CX3CR1-expressing cells become numerous in the inner ear after excessive noise exposure and in response to aminoglycoside ototoxicity, while CCR2-expressing cells enter the cochlea after ...

Ototoxicity has been reported with the use ... Avoid concomitant use of ARIKAYCE with ethacrynic acid, furosemide, urea, or intravenous mannitol. Overdosage: Adverse reactions specifically ...

—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $104.4 Million for Fourth-Quarter and $363.7 Million for Full-Year 2024, Reflecting 19% Annual Growth and Exceeding the ...

Neonatal intensive care of more than 5 days or any of the following regardless of length of stay: extracorporeal membrane oxygenation,* assisted ventilation, exposure to ototoxic drugs (gentamicin and ...

However, a doctor will address any underlying causes and may prescribe medications such as furosemide or heparin to reduce fluids in the body. Edema is swelling due to liquid trapped in the body ...

66, 67 In addition to the aforementioned processes, the use of ototoxic medicines such as hydroxychloroquine, favipiravir, azithromycin, and furosemide to treat COVID might result in reversible or ...

-ARIKAYCE ® (amikacin liposome inhalation suspension) Total Revenue of $104.4 Million for Fourth-Quarter and $363.7 Million for Full-Year 2024, Reflecting 19% Annual Growth and Exceeding the ...